Helping Clinicians Cope for Burnout
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help gynecologic oncology clinicians manage burnout through a workshop initially designed for ovarian cancer patients. The adapted version, HOPE-C (Adapted Helping Ovarian Cancer Patients Cope Intervention), encourages clinicians to share experiences and discover positive stress management techniques. Participants will attend weekly sessions over a month, learning strategies to manage uncertainty and find meaning in their work. Clinicians working with ovarian cancer patients, such as doctors, nurses, and social workers, who feel stressed or overwhelmed, may find this trial beneficial. As an unphased trial, it offers clinicians a unique opportunity to explore innovative coping strategies in a supportive environment.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this intervention is safe for clinicians?
Research has shown that the original Helping Ovarian Cancer Patients Cope (HOPE) program has been well-received by patients. This program fosters hope and creates positive narratives, enhancing patients' emotional well-being. The new version, HOPE-C, is currently being tested to address burnout among doctors and nurses. Although specific safety data for this new version is not yet available, the original program reported no major issues or side effects. Since the HOPE-C program involves discussion and experience-sharing, it is likely safe and manageable. It aims to support healthcare providers by reducing stress and burnout.12345
Why are researchers excited about this trial?
Researchers are excited about the Helping Clinicians Cope intervention because it takes a fresh approach to tackling burnout by drawing from a program originally designed for cancer patients. Unlike typical burnout treatments that might focus on stress management or time off, this intervention encourages clinicians to reshape their personal narratives, manage uncertainty, and find meaning in their work. The personalized sessions are concise, lasting only 30-45 minutes once a week, allowing busy healthcare professionals to easily integrate them into their schedules. This unique adaptation aims to create lasting mental resilience, offering a potentially transformative tool in the fight against burnout.
What evidence suggests that the HOPE-C intervention is effective for addressing burnout?
Research has shown that the Helping Ovarian Cancer Patients Cope (HOPE) program reduces stress and improves emotional well-being in ovarian cancer patients. This program uses positive storytelling to help patients create hopeful narratives and manage uncertainties. In this trial, clinicians will engage in the adapted version for healthcare providers, called HOPE-C, which aims to reduce burnout by fostering peer support and offering new perspectives on challenging experiences. Although specific data on HOPE-C is limited, its foundation on the successful HOPE program suggests it could alleviate burnout among gynecologic oncology clinicians. Early signs indicate it may enhance mental health and job satisfaction.12456
Who Is on the Research Team?
Megan J. Shen, PhD
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Are You a Good Fit for This Trial?
This trial is for gynecologic oncology clinicians experiencing burnout. It aims to improve their well-being by adapting the HOPE intervention, originally designed for ovarian cancer patients, to address clinician stress and prevent professional errors and distress.Inclusion Criteria
Timeline for a Trial Participant
Development of Intervention
Clinicians review HOPE-C intervention materials and complete an interview and questionnaire on study.
Pilot Trial
Clinicians attend HOPE-C sessions once weekly for 4 weeks, with each session lasting approximately 30-45 minutes.
Follow-up
Clinicians may undergo an interview after completing HOPE-C sessions to provide feedback on the intervention.
What Are the Treatments Tested in This Trial?
Interventions
- Adapted Helping Ovarian Cancer Patients Cope Intervention
Trial Overview
The study tests an adapted Helping Ovarian Cancer Patients Cope (HOPE) program tailored for clinicians. Through interviews, surveys, and behavioral interventions, it seeks to foster peer support and help clinicians reframe challenging experiences positively.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
OBJECTIVE 1 DEVELOPMENT OF INTERVENTION: Clinicians review HOPE-C intervention materials and complete an interview and questionnaire on study. Feedback from Objective 1 will be incorporated into the HOPE-C intervention delivered in Objective 2. OBJECTIVE 2 PILOT TRIAL: Clinicians attend HOPE-C sessions (changing their narrative, managing life's uncertainty and finding meaning) once weekly for 4 weeks, with each session lasting approximately 30-45 minutes. Clinicians complete a questionnaire before and after completing all HOPE-C sessions. OBJECTIVE 3: Clinicians may undergo an interview after completing HOPE-C sessions.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer Center
Lead Sponsor
Andy Hill CARE Fund
Collaborator
Citations
Adapted Helping Ovarian Cancer Patients Cope ...
This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among ...
Adapted Helping Ovarian Cancer Patients Cope ...
This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among gynecologic oncology ...
Helping Ovarian Cancer Patients Cope with Their Illness ...
This clinical trial compares the effect of the Helping Ovarian Cancer Patients Cope with Their Disease (HOPE) intervention to usual care for the reduction ...
Adapted Helping Ovarian Cancer Patients Cope Intervention to ...
This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among gynecologic oncology ...
Helping Ovarian Cancer Patients Cope With Their Illness ...
This clinical trial compares the effect of the Helping Ovarian Cancer Patients Cope with Their Disease (HOPE) intervention to usual care for the reduction ...
H.O.P.E: Helping Ovarian Cancer Patients Cope
A method used to assign participants to an arm of a clinical study. The types of allocation are randomized allocation and nonrandomized. ... A group or subgroup ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.